The Collective Voice for GI Cancers

2025 Stomach Cancer Advisory Board sponsored by Amgen, ASCO GI, San Francisco
2025 Stomach Cancer Advisory Board sponsored by Amgen, ASCO GI, San Francisco

Trusted Partners

Convening

United Voices

Collaborating

Strong Patients

Advocating

Empowered Professionals

Educating

"Partnering with the GI Cancers Alliance is invaluable. They foster collaboration among gastrointestinal cancer organizations, amplifying our reach to patients and communities. Their collective voice ensures patient needs remain central, enabling organizations like ours to make a greater impact."

– Florian Mshanga, Executive Director, Feliciana Mshanga Memorial Cancer Foundation (Tanzania)

"There are many amazing organizations in the gastrointestinal cancer space. But we need a convener to pull us out of our siloes and work together for maximum reach and impact. The GI Cancers Alliance fills this role beautifully. We are truly grateful for them."

– Trevor Maxwell, stage IV colon cancer survivor, Founder, Man Up to Cancer

Trevor Maxwell

"The GI Cancers Alliance is a wonderful collaborator, aligning with our patient-focused mandate to support patients and caregivers with compassion and evidence. They have made a profound impact on our organization’s growth and on Canadian patients. We are grateful for the partnership."

– Filomena Servidio-Italiano, President & CEO, Colorectal Cancer Resource & Action Network (CCRAN)

Education

Test Your Biomarkers

Before patients begin a treatment plan, it's important to ask about biomarkers. Biomarkers can help you understand what your tumor is made of, and they can also let you know what treatments you may qualify for or which treatments are unlikely to work. Many clinical trials are designed around biomarkers. The first step is getting tested.